Galanthamine
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Galanthamine
Description :
Galanthamine is a potent acetylcholinesterase (AChE) inhibitor with an IC50 of 500 nM.Product Name Alternative :
GalantamineUNSPSC :
12352005Hazard Statement :
H301, H315, H317, H331Target :
Apoptosis; Cholinesterase (ChE)Type :
Natural ProductsRelated Pathways :
Apoptosis; Neuronal SignalingApplications :
Neuroscience-NeurodegenerationField of Research :
Neurological DiseaseAssay Protocol :
https://www.medchemexpress.com/Galanthamine.htmlPurity :
99.90Solubility :
DMSO : ≥ 59 mg/mLSmiles :
O[C@@H]1C[C@@H]2OC3=C4C(CN(C)CC[C@]42C=C1)=CC=C3OCMolecular Formula :
C17H21NO3Molecular Weight :
287.36Precautions :
H301, H315, H317, H331References & Citations :
[1]Melanie-Jayne R. Howes, et al. Acetylcholinesterase inhibitors of natural origin. International Journal of Research in Pharmaceutical and Biomedical Sciences 3 (SI 1) :67-86.|[2]Kuryatov A, et al. Roles of accessory subunits in alpha4beta2 (*) nicotinic receptors. Mol Pharmacol. 2008 Jul;74 (1) :132-43.|[3]Kita Y, et al. Galantamine increases hippocampal insulin-like growth factor 2 expression via α7 nicotinic acetylcholine receptors in mice. Psychopharmacology (Berl) . 2013 Feb;225 (3) :543-51.Shipping Conditions :
Room TemperatureStorage Conditions :
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category :
Natural ProductsClinical Information :
LaunchedIsoform :
AChECitation 01 :
Antioxidants (Basel) . 2022 Feb 14;11 (2) :385.|Asian Pac J Trop Med. 2018, 8 (10) :500-512.|Biochem Pharmacol. 2020 Oct;180:114139.|bioRxiv. 2024 Apr 3:2023.06.02.542933.|bioRxiv. 2025 Sep 21.|J Chromatogr A. 2023 Oct 11:1708:464330.|J Pharmacol Sci. 2022 Apr;148 (4) :364-368.|Microorganisms. 2022 Oct 21;10 (10) :2089.|Nat Commun. 2023 Apr 17;14 (1) :2182.|PLoS Biol. 2024 Jun 27;22 (6) :e3002672.|Research Square Preprint. June 16th, 2022.|Acta Pharmacol Sin. 2024 Jun;45 (6) :1160-1174.|Antioxidants (Basel) . 2022 Jun 23;11 (7) :1228.|Free Radic Biol Med. 2019 Dec;145:20-32.|Heliyon. 2024 Jun 3;10 (11) :e32322.CAS Number :
[357-70-0]

